Aveo Pharmaceuticals jumps over 6% to $7.30 after tivozanib phase 3 update
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aveo Pharmaceuticals presents new data from Phase 3 TIVO-3 trial of tivozanib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ayala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
- First Patient Dosed in Phase 1 AL102 Combination Trial with Novartis' Anti-BCMA Agent for the Treatment of Multiple Myeloma - - On Track to Initiate AL102 Phase 2/3 Pivotal Trial for the Treatment of.....»»
Eupraxia Pharmaceuticals Inc. Provides Corporate Update and Reports First Quarter 2021 Financial Results
VICTORIA, BC, May 13, 2021 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX:EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug deli.....»»
Reviva"s stock jumps after experimental schizophrenia drug meets endpoint in Phase 2 clinical trial
Shares of Reviva Pharmaceuticals Holdings Inc. soared 76.6% in trading on Monday after the company said its experimental treatment .....»»
Clovis jumps 20% to $6.39 per share after Phase 3 study update on Rubraca at SGO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rhythm Pharmaceuticals to provide update on Phase 2 Basket study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mid-Day Market Update: TriState Capital Jumps Following Q1 Results; Cyclacel Pharmaceuticals Shares Plunge
Midway through trading Tuesday, the Dow traded down 2.88% to 22968.65 while the NASDAQ fell 3.94% to 8223.52......»»
Milestone Pharmaceuticals Reports Fourth Quarter and Year-end 2019 Financial Results and Provides Clinical and Corporate Update
– Topline data from Phase 3 NODE-301 trial of etripamil in pati.....»»
Milestone Pharmaceuticals Reports Fourth Quarter and Year-end 2019 Financial Results and Provides Clinical and Corporate Update
– Topline data from Phase 3 NODE-301 trial of etripamil in patients with PSVT expected this month – MONTREAL and CHARLOTTE, N.C., March 6,.....»»
Aveo Pharmaceuticals appoints Erick Lucera as CFO amid coming tivozanib NDA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mid-Day Market Update: Neovasc Jumps After Submitting Approval Application For Neovasc Reducer; EyeGate Pharmaceuticals Shares Plummet
Midway through trading Tuesday, the Dow traded down 0.22% to 28398.61 while the NASDAQ fell 0.08% to 8938.93. The S&P also fell, dropping 0.16% to 3,216.21. 0 read more.....»»
Mid-Day Market Update: Cardlytics Jumps On Upbeat Q3 Results; Diffusion Pharmaceuticals Shares Plunge
Midway through trading Wednesday, the Dow traded up 0.04% to 27,701.84 while the NASDAQ fell 0.06% to 8,481.28. The S&P also rose, gaining 0.03% to 3,092.80. 0 read more.....»»
Mid-Day Market Update: Cardlytics Jumps On Upbeat Q3 Results; Diffusion Pharmaceuticals Shares Plunge
Midway through trading Wednesday, the Dow traded up 0.04% to 27,701.84 while the NASDAQ fell 0.06% to 8,481.28. The S&P also rose, gaining 0.03%.....»»
Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
 -- Reported Positive Topline Results from Pivotal Phase 3 URIROX-1 Trial.....»»
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter Financial Results
 Positive Phase 2 IV ganaxolone data in RSE .....»»
Aveo Pharmaceuticals provides update after FDA meeting discussing TIVO-3 results
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mid-Day Market Update: Achillion Pharmaceuticals Jumps Following Acquisition News; Natera Shares Plunge
Midway through trading Wednesday, the Dow traded up 0.07% to 27043.10 while the NASDAQ fell 0.24% to 8129.48. The S&P also fell, dropping 0.06% to.....»»
Mid-Day Market Update: Achillion Pharmaceuticals Jumps Following Acquisition News; Natera Shares Plunge
Midway through trading Wednesday, the Dow traded up 0.07% to 27043.10 while the NASDAQ fell 0.24% to 8129.48. The S&P also fell, dropping 0.06% to 2,993.98. read more.....»»
Rhythm Pharmaceuticals to provide update on expanded Phase 2 Basket Study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Boston biotech Rhythm"s stock jumps on success of drug for rare form of obesity
Shares of Boston startup Rhythm Pharmaceuticals jumped 20 percent Wednesday after the company announced its drug for two genetic forms of obesity succeeded in a late-stage trial. In a phase 3 trial, Rhythm’s (Nasdaq: RYTM) drug setmelanotide was .....»»